Net Income - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Net Income
$126m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$38B
CAGR 3-Years
29%
CAGR 5-Years
18%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$6.5B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$13.8B
CAGR 3-Years
55%
CAGR 5-Years
8%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Net Income
$7.3B
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
8%

See Also

What is Corcept Therapeutics Inc's Net Income?
Net Income
126m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Net Income amounts to 126m USD.

What is Corcept Therapeutics Inc's Net Income growth rate?
Net Income CAGR 5Y
10%

Over the last year, the Net Income growth was 33%. The average annual Net Income growth rates for Corcept Therapeutics Inc have been 9% over the past three years , 10% over the past five years .

Back to Top